FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye

(2015) L J Melchers et al.   BRITISH JOURNAL OF CANCER

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers

(2015) F. Goke et al.   CLINICAL CANCER RESEARCH

Comprehensive genomic characterization of head and neck squamous cell carcinomas

(2015)   NATURE

Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review

(2015) Norbertus A. Ipenburg et al.   Targeted Oncology

Paralog-Specific Kinase Inhibition of FGFR4: Adding to the Arsenal of Anti-FGFR Agents

(2015) L. M. Packer et al.   Cancer Discovery

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

(2015) M. Hagel et al.   Cancer Discovery

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

(2014) J.- C. Soria et al.   ANNALS OF ONCOLOGY

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

(2014) Tanguy Y. Seiwert et al.   CLINICAL CANCER RESEARCH

Translational genomics and head and neck cancer: toward precision medicine

(2014) S. Razzouk   CLINICAL GENETICS

Head and Neck Squamous Cell Carcinomas Do Not Express EGFRvIII

(2014) Lieuwe J. Melchers et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Emerging biomarkers in head and neck cancer in the era of genomics

(2014) Hyunseok Kang et al.   Nature Reviews Clinical Oncology

Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer

(2014) Simone Bertz et al.   VIRCHOWS ARCHIV

HPV-positive oropharyngeal squamous cell carcinoma is associated withTIMP3andCADM1promoter hypermethylation

(2014) Pauline M. W. van Kempen et al.   Cancer Medicine

The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1

(2013) P T Nguyen et al.   BRITISH JOURNAL OF CANCER

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

(2013) F. Andre et al.   CLINICAL CANCER RESEARCH

Molecularly targeted cancer therapy: some lessons from the past decade

(2013) Min Huang et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives

(2013) Maria Vittoria Dieci et al.   Cancer Discovery

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

(2012) Karel G M Moons et al.   HEART

FGFR4 Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Mouth and Oropharynx

(2012) Roberta Lelis Dutra et al.   PLoS One

Influence of HPV16 E6/7 on the Expression of FGF2 and FGFR Type B in Cervical Carcinogenesis

(2012) Ya-Min Cheng et al.   Reproductive Sciences

The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer

(2010) W J Pattje et al.   BRITISH JOURNAL OF CANCER

Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis

(2010) D. Pulte et al.   ONCOLOGIST